Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of oral doses of FB-101 in healthy subjects.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - FB-101

Part A - Single Ascending Dose study Part B - Multiple Ascending Dose study

Drug - Placebo

Part A - Single Ascending Dose matching placebo study Part B - Multiple Ascending Dose matching placebo study

Additional Information

Official Study Title

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects

Clinical Trial ID

NCT04165837

ParticipAid ID

ejRp5e